{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T12:18:36Z","timestamp":1795177116575,"version":"4.10.3"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union","award":["PI22\/01804"],"award-info":[{"award-number":["PI22\/01804"]}],"id":[{"id":"https:\/\/ror.org\/019w4f821","id-type":"ROR","asserted-by":"crossref"}]},{"name":"European Union","award":["PI25\/00647"],"award-info":[{"award-number":["PI25\/00647"]}],"id":[{"id":"https:\/\/ror.org\/019w4f821","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Gonzalo Mi\u00f1o Grant Asociaci\u00f3n Espa\u00f1ola de Gastroenterolog\u00eda","id":[{"id":"https:\/\/ror.org\/05sv06075","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1 R01 AR081382-01A1"],"award-info":[{"award-number":["1 R01 AR081382-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Gastroesophageal reflux disease (GERD) is highly prevalent in SSc and frequently persists despite proton pump inhibitor (PPI) therapy. We aimed to characterize the contribution of oesophageal and gastric dysmotility to PPI-refractory GERD in SSc.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a single\u2011centre, retrospective study of adults with SSc who underwent ambulatory pH\u2013multichannel intraluminal impedance (pH\/MII) monitoring while receiving twice\u2011daily PPI therapy (2021\u201325). Oesophageal motility (high\u2011resolution manometry, HREM) and gastric emptying scintigraphy were integrated to examine associations between gastro-oesophageal dysmotility and reflux phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty patients were included, of whom 67% had PPI-refractory reflux symptoms and 33% were undergoing pre\u2013lung transplantation evaluation. Refractory GERD was present in 29\/30 patients (97%) based on Lyon 2.0 classification, with conclusive evidence in 53% and borderline evidence in 43%. Oesophageal dysmotility was identified in 80%, most commonly absent contractility (67%), and was associated with impaired reflux clearance, reflected by longer acid clearance times [2.20 (1.15\u20133.75) vs 1.15 (0.43\u20131.90) min] and more prolonged reflux episode duration [16.60 (4.38\u201340.63) vs 1.95 (0.53\u201320.43) min]. Gastric dysmotility was identified in 60.7% and was associated with an increased reflux episode burden [51.00 (30.00\u201381.50) vs 25.00 (21.00\u201354.00) episodes\/24 h].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PPI\u2011refractory GERD is nearly universal in this SSc cohort and reflects heterogeneous, quantifiable abnormalities across the foregut, including impaired oesophageal clearance and increased reflux burden related to gastric retention. These findings support integrated physiologic evaluation to define reflux mechanisms, inform risk stratification (including lung transplantation) and guide targeted, mechanism-based therapies beyond acid suppression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keag451","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:45:39Z","timestamp":1787139939000},"source":"Crossref","is-referenced-by-count":1,"title":["PPI-refractory GERD in SSc is driven by distinct oesophageal and gastric motility abnormalities"],"prefix":"10.1093","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3247-1539","authenticated-orcid":false,"given":"Luis G","family":"Alcala-Gonzalez","sequence":"first","affiliation":[{"name":"Digestive System Research Unit, Department of Digestive Diseases, Vall d\u2019Hebron University Hospital , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0626-507X","authenticated-orcid":false,"given":"Alfredo","family":"Guillen-del-Castillo","sequence":"additional","affiliation":[{"name":"Systemic Autoimmune Diseases Unit, Internal Medicine Department, Vall d\u2019Hebron University Hospital , Barcelona,","place":["Spain"]},{"name":"Department of Medicine, Universitat Autonoma de Barcelona , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6138-3741","authenticated-orcid":false,"given":"Francisco A","family":"Felix-Tellez","sequence":"additional","affiliation":[{"name":"Digestive System Research Unit, Department of Digestive Diseases, Vall d\u2019Hebron University Hospital , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2040-311X","authenticated-orcid":false,"given":"Ariadna","family":"Aguilar","sequence":"additional","affiliation":[{"name":"Digestive System Research Unit, Department of Digestive Diseases, Vall d\u2019Hebron University Hospital , Barcelona,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (Ciberehd) , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4711-2731","authenticated-orcid":false,"given":"Claudia","family":"Barber","sequence":"additional","affiliation":[{"name":"Digestive System Research Unit, Department of Digestive Diseases, Vall d\u2019Hebron University Hospital , Barcelona,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (Ciberehd) , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7097-1492","authenticated-orcid":false,"given":"Carolina","family":"Malagelada","sequence":"additional","affiliation":[{"name":"Digestive System Research Unit, Department of Digestive Diseases, Vall d\u2019Hebron University Hospital , Barcelona,","place":["Spain"]},{"name":"Department of Medicine, Universitat Autonoma de Barcelona , Barcelona,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (Ciberehd) , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1439-2171","authenticated-orcid":false,"given":"Laura","family":"Polo Figueras","sequence":"additional","affiliation":[{"name":"Digestive System Research Unit, Department of Digestive Diseases, Vall d\u2019Hebron University Hospital , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2224-2987","authenticated-orcid":false,"given":"Laura","family":"Triginer","sequence":"additional","affiliation":[{"name":"Systemic Autoimmune Diseases Unit, Internal Medicine Department, Vall d\u2019Hebron University Hospital , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8083-5897","authenticated-orcid":false,"given":"Claudia","family":"Codina-Clavaguera","sequence":"additional","affiliation":[{"name":"Systemic Autoimmune Diseases Unit, Internal Medicine Department, Vall d\u2019Hebron University Hospital , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3361-4909","authenticated-orcid":false,"given":"Michael","family":"Hughes","sequence":"additional","affiliation":[{"name":"Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biological Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre , Manchester,","place":["UK"]},{"name":"Salford Care Organisation, Northern Care Alliance NHS Foundation Trust , Salford,","place":["UK"]},{"name":"NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust , Manchester,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3390-9029","authenticated-orcid":false,"given":"Carmen P","family":"Sime\u00f3n-Aznar","sequence":"additional","affiliation":[{"name":"Systemic Autoimmune Diseases Unit, Internal Medicine Department, Vall d\u2019Hebron University Hospital , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2120-6270","authenticated-orcid":false,"given":"Jordi","family":"Serra","sequence":"additional","affiliation":[{"name":"Digestive System Research Unit, Department of Digestive Diseases, Vall d\u2019Hebron University Hospital , Barcelona,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (Ciberehd) , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6461-8940","authenticated-orcid":false,"given":"Zsuzsanna H","family":"McMahan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Rheumatology, UTHealth Houston , Houston, TX,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"2026092513475277600_keag451-B1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41584-022-00900-6","article-title":"Systemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and management","volume":"19","author":"McMahan","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"2026092513475277600_keag451-B2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/BOR.0000000000001110","article-title":"Gastrointestinal manifestations of systemic sclerosis: current approaches and emerging therapies","volume":"37","author":"Alcala-Gonzalez","year":"2025","journal-title":"Curr Opin Rheumatol"},{"key":"2026092513475277600_keag451-B3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/1744666X.2024.2320205","article-title":"Managing gastrointestinal manifestations in systemic sclerosis, a mechanistic approach","volume":"20","author":"Kaniecki","year":"2024","journal-title":"Expert Rev Clin Immunol"},{"key":"2026092513475277600_keag451-B4","doi-asserted-by":"publisher","first-page":"keag070","DOI":"10.1093\/rheumatology\/keag070","article-title":"Delayed gastric emptying identifies a high-risk clinical subgroup in patients with systemic sclerosis","volume":"65","author":"Felix-Tellez","year":"2026","journal-title":"Rheumatology"},{"key":"2026092513475277600_keag451-B5","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.1093\/rheumatology\/keaf433","article-title":"Oesophageal dysmotility patterns are associated with distinct clinical phenotypes and prognosis in patients with systemic sclerosis","volume":"64","author":"Alcala-Gonzalez","year":"2025","journal-title":"Rheumatology"},{"key":"2026092513475277600_keag451-B6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.semarthrit.2006.08.002","article-title":"Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem","volume":"36","author":"Ntoumazios","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"2026092513475277600_keag451-B7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000489848","article-title":"Gastroesophageal reflux disease-related disorders of systemic sclerosis based on the analysis of 66 patients","volume":"98","author":"Matsuda","year":"2018","journal-title":"Digestion"},{"key":"2026092513475277600_keag451-B8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/gastro\/goaa096","article-title":"Higher risk of neoplastic progression of Barrett\u2019s esophagus in patients with systemic sclerosis","volume":"9","author":"Anilkumar","year":"2021","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"2026092513475277600_keag451-B9","doi-asserted-by":"publisher","first-page":"SI63","DOI":"10.1093\/rheumatology\/keaf016","article-title":"Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort","volume":"64","author":"Roth","year":"2025","journal-title":"Rheumatol Oxf Engl"},{"key":"2026092513475277600_keag451-B10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.gtc.2020.04.004","article-title":"Esophageal evaluation for patients undergoing lung transplant evaluation: what should we do for evaluation and management","volume":"49","author":"Malik","year":"2020","journal-title":"Gastroenterol Clin North Am"},{"key":"2026092513475277600_keag451-B11","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1093\/rheumatology\/keae481","article-title":"Gastrointestinal dysmotility is associated with proton pump inhibitor refractory esophagitis in patients with systemic sclerosis","volume":"64","author":"Alcala-Gonzalez","year":"2025","journal-title":"Rheumatol Oxf Engl"},{"key":"2026092513475277600_keag451-B12","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41598-020-57636-0","article-title":"Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study","volume":"10","author":"Foocharoen","year":"2020","journal-title":"Sci Rep"},{"key":"2026092513475277600_keag451-B13","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1093\/rheumatology\/kead486","article-title":"Significant gastrointestinal unmet needs in patients with Systemic Sclerosis: insights from a large international patient survey","volume":"63","author":"Bandini","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2026092513475277600_keag451-B14","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/acr.25280","article-title":"A multinational survey investigating the unmet needs and patient perspectives concerning proton pump inhibitors in systemic sclerosis","volume":"76","author":"Bandini","year":"2024","journal-title":"Arthritis Care Res"},{"key":"2026092513475277600_keag451-B15","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/nmo.12813","article-title":"The association between systemic sclerosis disease manifestations and esophageal high-resolution manometry parameters","volume":"28","author":"Kimmel","year":"2016","journal-title":"Neurogastroenterol Motil"},{"key":"2026092513475277600_keag451-B16","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/acr.25080","article-title":"Associations between patterns of esophageal dysmotility and extra-intestinal features in patients with systemic sclerosis","volume":"75","author":"Tucker","year":"2023","journal-title":"Arthritis Care Res"},{"key":"2026092513475277600_keag451-B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/dote\/dox067","article-title":"Spectrum of esophageal dysmotility in systemic sclerosis on high-resolution esophageal manometry as defined by Chicago classification","volume":"30","author":"Aggarwal","year":"2017","journal-title":"Dis Esophagus Off J Int Soc Dis Esophagus"},{"key":"2026092513475277600_keag451-B18","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s10067-018-4026-1","article-title":"Esophageal high-resolution impedance manometry alterations in asymptomatic patients with systemic sclerosis: prevalence, associations with disease features, and prognostic value","volume":"37","author":"Vettori","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2026092513475277600_keag451-B19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10067-019-04794-w","article-title":"The role of high-resolution manometry in the assessment of upper gastrointestinal involvement in systemic sclerosis: a systematic review","volume":"39","author":"Schutyser","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2026092513475277600_keag451-B20","doi-asserted-by":"publisher","first-page":"102117","DOI":"10.1016\/j.berh.2026.102117","article-title":"Gastrointestinal involvement in systemic sclerosis: a spotlight on small bowel involvement, complications and management","volume":"40","author":"Alcala-Gonzalez","year":"2026","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2026092513475277600_keag451-B21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/14656566.2025.2470846","article-title":"Systemic pharmacotherapy approaches for the treatment of systemic sclerosis","volume":"26","author":"Di Donato","year":"2025","journal-title":"Expert Opin Pharmacother"},{"key":"2026092513475277600_keag451-B22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1136\/gutjnl-2023-330616","article-title":"Updates to the modern diagnosis of GERD: Lyon consensus 2.0","volume":"73","author":"Gyawali","year":"2024","journal-title":"Gut"},{"key":"2026092513475277600_keag451-B23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.14309\/ajg.0000000000001538","article-title":"ACG clinical guideline: guidelines for the diagnosis and management of gastroesophageal reflux disease","volume":"117","author":"Katz","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"2026092513475277600_keag451-B24","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2026092513475277600_keag451-B25","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"2026092513475277600_keag451-B26","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1093\/rheumatology\/kead520","article-title":"Anti-nuclear valosin-containing protein-like autoantibody is associated with calcinosis and higher risk of cancer in systemic sclerosis","volume":"63","author":"Perurena-Prieto","year":"2024","journal-title":"Rheumatol Oxf Engl"},{"key":"2026092513475277600_keag451-B27","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1016\/j.cgh.2020.09.002","article-title":"Inter-reviewer variability in interpretation of pH-impedance studies: the wingate consensus","volume":"19","author":"Gyawali","year":"2021","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"2026092513475277600_keag451-B28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cgh.2015.06.026","article-title":"Analyses of the post-reflux swallow-induced peristaltic wave index and nocturnal baseline impedance parameters increase the diagnostic yield of impedance-pH monitoring of patients with reflux disease","volume":"14","author":"Frazzoni","year":"2016","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"2026092513475277600_keag451-B29","doi-asserted-by":"publisher","first-page":"e70072","DOI":"10.1111\/nmo.70072","article-title":"Practical validation of the COuGH RefluX score: a multicenter study in patients from Hispano-America","volume":"37","author":"Alcala-Gonzalez","year":"2025","journal-title":"Neurogastroenterol Motil"},{"key":"2026092513475277600_keag451-B30","doi-asserted-by":"publisher","first-page":"e14058","DOI":"10.1111\/nmo.14058","article-title":"Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0\u00a9","volume":"33","author":"Yadlapati","year":"2021","journal-title":"Neurogastroenterol Motil"},{"key":"2026092513475277600_keag451-B31","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/ueg2.12565","article-title":"The Milan score: a novel manometric tool for a more efficient diagnosis of gastro-esophageal reflux disease","volume":"12","author":"Siboni","year":"2024","journal-title":"United Eur Gastroenterol J"},{"key":"2026092513475277600_keag451-B32","doi-asserted-by":"publisher","first-page":"e70088","DOI":"10.1111\/nmo.70088","article-title":"Assessment of esophagogastric junction barrier function with the supine-upright transition of the chicago classification protocol","volume":"37","author":"Siboni","year":"2025","journal-title":"Neurogastroenterol Motil"},{"key":"2026092513475277600_keag451-B33","doi-asserted-by":"publisher","first-page":"e14643","DOI":"10.1111\/nmo.14643","article-title":"Distinctive gastrointestinal motor dysfunction in patients with MNGIE","volume":"35","author":"Alcal\u00e1-Gonz\u00e1lez","year":"2023","journal-title":"Neurogastroenterol Motil"},{"key":"2026092513475277600_keag451-B34","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.cgh.2017.09.033","article-title":"Interchangeable use of proton pump inhibitors based on relative potency","volume":"16","author":"Graham","year":"2018","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"2026092513475277600_keag451-B35","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13247","article-title":"Abnormal esophageal acid exposure on high-dose proton pump inhibitor therapy is common in systemic sclerosis patients","volume":"30","author":"Stern","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"2026092513475277600_keag451-B36","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/apt.70245","article-title":"Combined Lyon and Milan scores predict GERD management outcome better than either score alone or their individual components","volume":"62","author":"Siboni","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"2026092513475277600_keag451-B37","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/ajg.2014.61","article-title":"Assessing Bolus retention in achalasia using high resolution manometry with impedance: a comparator study with timed barium esophagram","volume":"109","author":"Cho","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"2026092513475277600_keag451-B38","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1111\/j.1572-0241.2005.00303.x","article-title":"Multichannel intraluminal impedance monitoring in the evaluation of patients with non-obstructive Dysphagia","volume":"100","author":"Conchillo","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"2026092513475277600_keag451-B39","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.medcli.2024.07.026","article-title":"Patient perspectives and treatment gaps in managing gastrointestinal symptoms in systemic sclerosis","volume":"164","author":"Alcala-Gonzalez","year":"2025","journal-title":"Med Clin (Barc)"},{"key":"2026092513475277600_keag451-B40","doi-asserted-by":"publisher","first-page":"502705","DOI":"10.1016\/j.gastrohep.2026.502705","article-title":"Proton pump inhibitor use and treatment satisfaction in spanish patients with systemic sclerosis: insights from a Nationwide Survey","volume":"49","author":"Felix-Tellez","year":"2026","journal-title":"Gastroenterol Hepatol"},{"key":"2026092513475277600_keag451-B41","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11894-005-0033-x","article-title":"Gastroesophageal reflux and gastric emptying, revisited","volume":"7","author":"Emerenziani","year":"2005","journal-title":"Curr Gastroenterol Rep"},{"key":"2026092513475277600_keag451-B42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1053\/j.gastro.2017.09.047","article-title":"Pathophysiology of gastroesophageal reflux disease","volume":"154","author":"Tack","year":"2018","journal-title":"Gastroenterology"},{"key":"2026092513475277600_keag451-B43","doi-asserted-by":"publisher","first-page":"152944","DOI":"10.1016\/j.semarthrit.2026.152944","article-title":"Gastric disease in systemic sclerosis: spectrum, challenges, and insights from a systematic literature review","volume":"77","author":"Anderton","year":"2026","journal-title":"Semin Arthritis Rheum"},{"key":"2026092513475277600_keag451-B44","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1093\/rheumatology\/keaf064","article-title":"The role of prokinetics in managing gastrointestinal involvement in systemic sclerosis: a systematic literature review","volume":"64","author":"Ezquerra-Dur\u00e1n","year":"2025","journal-title":"Rheumatol Oxf Engl"},{"key":"2026092513475277600_keag451-B45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13075-016-1094-y","article-title":"The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial","volume":"18","author":"Karamanolis","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2026092513475277600_keag451-B46","doi-asserted-by":"publisher","first-page":"152791","DOI":"10.1016\/j.semarthrit.2025.152791","article-title":"The role of surgery in esophageal involvement in systemic sclerosis: a systematic literature review","volume":"74","author":"Matucci-Cerinic","year":"2025","journal-title":"Semin Arthritis Rheum"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keag451\/70724801\/keag451.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/9\/keag451\/70724801\/keag451.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/9\/keag451\/70724801\/keag451.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:48:00Z","timestamp":1790358480000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keag451\/8767196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keag451","relation":{},"ISSN":["1462-0332"],"issn-type":[{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,20]]},"article-number":"keag451"}}